Literature DB >> 12734677

Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes.

R Ali1, F Ozkalemkaş, T Ozçelik, V Ozkocaman, U Ozan, Y Kimya, N Köksal, E Bülbül-Başkan, O Develioğlu, M Tüfekçi, A Tunali.   

Abstract

We observed 13 pregnant women of 70 females with idiopathic thrombocytopenic purpura (ITP) from January 1992 through September 2002. Thirteen mothers with ITP gave birth to twelve babies and two fetuses died. One of the pregnancies produced twins. Seven of the cases were diagnosed with ITP before pregnancy and six during pregnancy. One of the thirteen pregnancies was complicated by preeclampsia, one by ablatio placentae, and one by intrauterine death. Seven mothers received corticosteroid treatment, four high-dose immunoglobulin therapies, and one underwent splenectomy in the second trimester of gestation. At the time of delivery six mothers had normal platelet counts and seven had low platelet counts. Nine deliveries were by vaginal route and four were by cesarean section. Eleven infants were born with normal platelet counts and one was thrombocytopenic at the time of delivery. No infant showed any clinical signs of hemorrhage and there were no neonatal complications. Two fetuses died; one of them because of ablatio placentae and the other was intrauterine dead. In conclusion, ITP in pregnancy requires the management of two patients, the mother and her baby; hence, the close collaboration of a multidisciplinary group composed of a hematologist, obstetrician, anesthesiologist, and neonatologist is essential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734677     DOI: 10.1007/s00277-003-0665-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  7 in total

1.  Immune thrombocytopenia in tuberculosis: causal or coincidental?

Authors:  Gopalakrishnan Srividya; Gopalakrishna Pillai Syamala Nikhila; Adusumilli Venkatakrishna Kaushik; Kuppusamy Jayachandran
Journal:  J Glob Infect Dis       Date:  2014-07

2.  Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.

Authors:  Susan D Mathias; Sue K Gao; Kimberly L Miller; David Cella; Claire Snyder; Ralph Turner; Albert Wu; James B Bussel; James N George; Robert McMillan; Diane Kholos Wysocki; Janet L Nichol
Journal:  Health Qual Life Outcomes       Date:  2008-02-08       Impact factor: 3.186

3.  Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP).

Authors:  Young-Woong Won; Won Moon; Yeong-Seop Yun; Ho-Suk Oh; Jung-Hye Choi; Young-Yeul Lee; In-Soon Kim; Il-Young Choi; Myung-Ju Ahn
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

4.  Is It a Coincidence or Secondary Immune Thrombocytopenic Purpura? A Case of an 11-Year-Old Male Patient at Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia.

Authors:  Worku Ketema; Kefyalew Taye; Negash Tagesse; Aberash Eifa
Journal:  Int Med Case Rep J       Date:  2022-03-05

5.  Tuberculosis presenting as immune thrombocytopenic purpura.

Authors:  Fahir Ozkalemkas; Ridvan Ali; Atilla Ozkan; Tulay Ozcelik; Vildan Ozkocaman; Esra Kunt-Uzaslan; Beril Bahadir-Erdogan; Halis Akalin
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-09-06       Impact factor: 3.944

6.  Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Sandra Regina Loggetto; Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Wanderley Marques Bernardo; Leticia Medeiros; Andrea Thives de Carvalho Hoepers
Journal:  Rev Bras Hematol Hemoter       Date:  2013

7.  Pregnancy outcomes in women with idiopathic thrombocytopenic purpura.

Authors:  Fakhrolmolouk Yassaee; Roghieh Eskandari; Zohreh Amiri
Journal:  Iran J Reprod Med       Date:  2012-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.